文献速递瓣膜外科

卢旺达17年心脏瓣膜手术经验

A 17-Year Experience of Valvular Heart Surgery in Rwanda.
PubMed 文献 · Ann Thorac Surg · 2025-06-21

该研究总结了2006至2023年卢旺达366例瓣膜手术患者的结果。30天死亡率为2.2%,平均随访7.8年全因死亡率为18.2%。机械瓣置换患者全因死亡率(15.6%)低于生物瓣患者(32.7%),主要因生物瓣衰败需再次手术。

要点

  • 卢旺达瓣膜手术以二尖瓣为主(66.7%),患者平均年龄25.0岁。
  • 30天死亡率为2.2%,体现患者选择与围术期管理的成功。
  • 机械瓣长期生存优于生物瓣(全因死亡率15.6% vs 32.7%)。

核心结论

  • 机械瓣置换较生物瓣置换显示更优的长期生存,主要因生物瓣衰败和再手术需求。

研究设计与样本

  • 回顾性队列研究,纳入卢旺达心脏手术登记中2006至2023年366例瓣膜手术患者。

主要发现

  • 平均手术年龄25.0岁(SD 10.2),女性占63.9%。
  • 二尖瓣手术单独占45.9%,联合三尖瓣手术占20.8%,合计66.7%。
  • 30天术后死亡率为2.2%。
  • 平均随访7.8年(SD 4.5),全因死亡率为18.2%。
  • 生物瓣患者全因死亡率32.7%,机械瓣患者15.6%(P = .008)。

关键数值与推荐

  • 机械瓣患者长期并发症以栓塞和出血为主(13.0%),生物瓣患者以结构性瓣膜衰败为主(26.5%)。

临床怎么用

  • 在资源有限地区,机械瓣可能因长期耐久性而优先考虑,但需加强术后随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The advanced presentation of rheumatic heart disease in Rwanda often necessitates surgical intervention. We summarize the outcomes of valvular heart operations in Rwanda between 2006 and 2023. METHODS: The study included 366 patients in the Rwandan cardiac surgery registry who underwent valvular surgery. We examined surgical details, perioperative outcomes, and long-term outcomes. Cox multivariable analyses were conducted to assess factors predictive of survival outcomes. Additionally, subgroup analyses compared outcomes between mechanical valve replacement and bioprosthetic valve replacement. RESULTS: The average age at surgery was 25.0 (SD, 10.2 years), with 63.9% of patients being female. Mitral valve surgery, alone (45.9%) or in conjunction with tricuspid valve surgery (20.8%), was the most common procedure (66.7%). The 30-day postoperative mortality rate was 2.2%. Over an average follow-up of 7.8 years (SD, 4.5 years), the all-cause mortality rate was 18.2%. Patients who received a bioprosthetic valve replacement had a higher all-cause mortality rate than those who received a mechanical valve replacement (32.7% vs 15.6%, P = .008). The most common long-term complications for mechanical valve patients were embolism and bleeding (13.0%) compared with structural valve deterioration (26.5%) in bioprosthetic valve patients. CONCLUSIONS: The low 30-day mortality rate reflects success in careful patient selection, meticulous surgery, and dedicated perioperative care. Mechanical valve replacement demonstrated superior long-term survival over bioprosthetic valve replacement mainly due to valve degeneration and need for reoperation in bioprosthetic valve patients. Key areas of improvement include strengthening postoperative follow-up and capacity for increased surgical complexity.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Musoni M, Wang S, Schulick N, et al. A 17-Year Experience of Valvular Heart Surgery in Rwanda. Ann Thorac Surg. 2025. PMID: 40550320. doi:10.1016/j.athoracsur.2025.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。